A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients

CMAJ. Canadian Medical Association Journal

Volumn 169, Issue 1, 2003, Pages 17-22

  Sellors, John ^a,b   Kaczorowski, Janusz ^a,b   Sellors, Connie ^a,b   Dolovich, Lisa ^a,b,c   Woodward, Christel ^a   Willan, Andrew ^a,b   Goeree, Ron ^a,b   Cosby, Roxanne ^a   Trim, Kristina ^a   Sebaldt, Rolf ^a,b   Howard, Michelle ^a   Hardcastle, Linda ^a   Poston, Jeff ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Canadian Pharmacists Association   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM; CLARITHROMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETIDRONIC ACID; FERROUS GLUCONATE; GLIBENCLAMIDE; IBUPROFEN; PARACETAMOL; SALBUTAMOL;

AGED; ARTICLE; CANADA; CLINICAL TRIAL; COMMUNITY; CONFUSION; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG COST; FEMALE; GENERAL PRACTITIONER; GERIATRIC CARE; GERIATRIC DISORDER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; OUTCOMES RESEARCH; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TEAMWORK; TRAINING; TREATMENT INDICATION;

EID: 0042848861     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Stewart RB. Polypharmacy in the elderly: a fait accompli? DICP: the annals of pharmacotherapy 1990;24:321-3.
2. Tamblyn RM, McLeod PJ, Abrahamowicz M, Monette J, Gayton DC, Berkson L, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994;150:1801-9.
3. Avorn J. Medication use and the elderly: current status and opportunities. Health Aff 1995;14:276-86.
4. Col N, Fanale JE, Konholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-5.
5. Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care 1991;29:989-1003.
6. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832-40.
7. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
8. Schmader K, Hanlon JT, Weinberger M, Landsman PB, Samsa GP, Lewis IK, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994;42:1241-7.
9. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-6.
10. Hogan DB, Ebly EM, Fung TS. Regional variations in use of potentially inappropriate medications by Canadian seniors participating in the Canadian Study of Health and Aging. Can J Clin Pharmacol 1995;2:167-74.
11. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996;154:1177-84.
12. Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001;286:2823-9.
13. Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000;34:338-46.
14. Sidel VW, Beizer JL, Lisi-Fazio D, Kleinmann K, Wenston J, Thomas C, et al. Controlled study of the impact of educational home visits by pharmacists to high-risk older patients. J Community Health 1990;15:163-74.
15. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care 1992;30:926-40.
16. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999;159:2306-9.
17. Lipton HL, Bero LA, Bird JA, McPhee S. The impact of clinical pharmacists' consultation on physician's geriatric drug prescribing. A randomized controlled trial. Med Care 1992;30:646-58.
18. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
19. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995;41:469-72.
20. Bernsten C, Björkman I, Caramona M, Crealey G, Frøkjær B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care. A multicentre study in seven European countries. Drugs Aging 2001;18:63-77.
21. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized controlled trial in primary care. Age Ageing 2001;30:205-11.
22. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc 2001;41:411-20.
23. Sellors J, Cosby R, Trim K, Kaczorowski J, Howard M, Hardcasde L, et al. Recruiting family physicians and patients for a clinical trial: lessons learned. Fam Pract 2002;19:99-104.
24. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
25. US Centers for Disease Control and Prevention. CDC Wonder. International classification of diseases. Available: http://wonder.cdc.gov/wonder/cgi-bin/asp/ICDFinder.asp (accessed 1999 Nov to 2000 Mar).
26. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Landsman GD. Drug-related problems: their structure and function. DICP: the annals of pharmacotherapy 1990;24:1093-7.
27. Sellors C, Dalby DM, Howard M, Kaczorowski J, Sellors J. A pharmacist consultation service in community-based family practices: a randomized controlled trial in seniors. J Pharm Technol 2001;17:264-9.
28. McHorney C, Ware JJ, Raczek AE. The MOS 36-item Short-Form health survey (SF-36):II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
29. Cosby RH, Howard M, Kaczorowski J, Willan A, Sellors JW. Randomizing patients by family practice: sample size estimation, intracluster correlation, and data analysis. Fam Pract 2003;20(1):77-82.
30. Thompson SG, Pyke SD, Hardy RJ. The design and analysis of paired cluster randomization trials: an application of meta-analysis techniques. Stat Med 1997;16:2063-79.
31. Canadian Medical Association-Canadian Pharmaceutical Association Joint Statement. Approaches to enhancing the quality of drug therapy. CMAJ 1996;155(6):784A-F.
32. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. [Cochrane review]. In: The Cochrane Library; Issue 4, 2002. Oxford: Update Software.
33. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med 1983;308:1457-63.
34. Morse GD, Douglas JB, Upton JH, Rodgers S, Gal P. Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm 1986;43:905-9.
35. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 1998;13:740-5.
36. Bogden PE, Koontz LM, Williamson P, Abbott RD. The physician and pharmacist team: an effective approach to cholesterol reduction. J Gen Intern Med 1997;12:158-64.
37. Tsuyuki RT, Johnson JA, Toe KT, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. Arch Int Med 2002;162:1149-55.
38. Ellis SL, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, et al. Types of interventions made by clinical pharmacists in the IMPROVE study. Pharmacotherapy 2000;20:429-35.
39. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:294-5.
40. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002;288:1594-602.
41. Grymonpre RE, Williamson DA, Montgomery PR. Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomized, controlled trial. Int J Pharm Pratt 2001;9:235-41.
42. Allard J, Hébert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001;164:1291-6.
43. Stadnyk K, Calder J, Rockwood K. Testing the measurement properties of the Short Form-36 health survey in a frail elderly population. J Clin Epidemiol 1998;51:827-35.